{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:43:38Z","timestamp":1783478618816,"version":"3.55.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Venous thromboembolism (VTE) is a leading cause of death in patients with cancer. Limited data exist about VTE in patients with adrenocortical carcinoma (ACC). The primary objective of this study was to identify the prevalence of VTE in a cohort of patients with ACC. Secondary objectives were to determine the impact of VTE events on overall survival (OS) and to describe the characteristics of VTE in patients with ACC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods<\/jats:title>\n                  <jats:p>We retrospectively reviewed data from 289 patients with ACC cared for at a major referral center from February 2010 to June 2022.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>VTE prevalence was 18.7% (54 events). Thirty patients (55.6%) had pulmonary embolism (PE); 12 patients (22.2%) had deep vein thrombosis (DVT); and 12 patients (22.2%) had both PE and DVT. VTE occurred after ACC diagnosis in 50 patients (92.6%) including 44 patients (88%) with stage 3 or 4 ACC. VTEs were CTCAE grade \u22642 in 32 cases (59.3%), grade 3 in 17 (31.5%), and grade 4 in 2 (3.7%). Thirteen patients (24%) died within 6 months after VTE diagnosis, although there was no statistically significant association between VTE and overall survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Despite the potential to underestimate the prevalence of VTEs, we found a high frequency of VTE events in patients with ACC. A majority of VTEs occurred in the context of advanced ACC and we observed high short-term mortality. Further studies are needed to validate our findings and investigate mechanisms associated with VTE in ACC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyae099","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T21:23:43Z","timestamp":1716413023000},"page":"575-580","source":"Crossref","is-referenced-by-count":3,"title":["Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis"],"prefix":"10.1093","volume":"29","author":[{"given":"Marta","family":"Lagan\u00e0","sequence":"first","affiliation":[{"name":"Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia at ASST Spedali Civili , Brescia , Italy"},{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9327-9615","authenticated-orcid":false,"given":"Vania","family":"Balderrama-Brondani","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey Ruth","family":"Herrera","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Chahla","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Yaylaci","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4534-2042","authenticated-orcid":false,"given":"Roland L","family":"Bassett","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-3355","authenticated-orcid":false,"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeena","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-0100","authenticated-orcid":false,"given":"Steven G","family":"Waguespack","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amishi Y","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhiam M","family":"Rojas Hernandez","sequence":"additional","affiliation":[{"name":"Section of Benign Hematology, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-9637","authenticated-orcid":false,"given":"Mouhammed Amir","family":"Habra","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"issue":"5","key":"2024070511392275600_CIT0001","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/clinem\/dgac046","article-title":"Temporal trends in outcomes in patients with adrenocortical carcinoma: a multidisciplinary referral-center experience","volume":"107","author":"Daher","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2024070511392275600_CIT0002","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"2024070511392275600_CIT0003","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2024070511392275600_CIT0004","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","article-title":"Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity","volume":"21","author":"Falanga","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2024070511392275600_CIT0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjsurg.2017.08.018","article-title":"Nationwide analysis of adrenocortical carcinoma reveals higher perioperative morbidity in functional tumors","volume":"216","author":"Parikh","year":"2018","journal-title":"Am J Surg"},{"issue":"9","key":"2024070511392275600_CIT0006","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1530\/EC-20-0299","article-title":"Venous thromboembolism in patients with adrenocortical carcinoma after surgery","volume":"9","author":"Durmusoglu","year":"2020","journal-title":"Endocr Connect"},{"issue":"7","key":"2024070511392275600_CIT0007","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jso.27059","article-title":"Risk factors for venous thromboembolism (VTE) after adrenalectomy for adrenal cortical neoplasms","volume":"126","author":"Moore","year":"2022","journal-title":"J Surg Oncol"},{"issue":"12","key":"2024070511392275600_CIT0008","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/jth.12028","article-title":"Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis","volume":"10","author":"Carrier","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2024070511392275600_CIT0009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"2024070511392275600_CIT0010","doi-asserted-by":"crossref","first-page":"18516","DOI":"10.1038\/s41598-020-75719-w","article-title":"Patterns and predictors of thromboembolic events among patients with gastric cancer","volume":"10","author":"Abdel-Razeq","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"2024070511392275600_CIT0011","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ajh.27106","article-title":"Long-term risk of venous thromboembolism among patients with gastrointestinal non-neoplastic and neoplastic diseases: a prospective cohort study of 484 211 individuals","volume":"99","author":"Yuan","year":"2023","journal-title":"Am J Hematol"},{"issue":"5","key":"2024070511392275600_CIT0012","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-019-0510-x","article-title":"The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues","volume":"121","author":"Campello","year":"2019","journal-title":"Br J Cancer"},{"issue":"6","key":"2024070511392275600_CIT0013","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"2024070511392275600_CIT0014","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/cancers12051291","article-title":"Venous thromboembolism in lymphoma: risk stratification and antithrombotic prophylaxis","volume":"12","author":"Hohaus","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"26","key":"2024070511392275600_CIT0015","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1182\/blood-2010-01-258624","article-title":"Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events","volume":"115","author":"Caruso","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2024070511392275600_CIT0016","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"issue":"4","key":"2024070511392275600_CIT0017","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"2024070511392275600_CIT0018","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing\u2019s syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2024070511392275600_CIT0019","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers","volume":"36","author":"Kastelan","year":"2009","journal-title":"Endocrine"},{"issue":"1","key":"2024070511392275600_CIT0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ejendo\/lvad176","article-title":"High prevalence of venous thrombotic events in Cushing\u2019s syndrome: data from ERCUSYN and details in relation to surgery","volume":"190","author":"Isand","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"29","key":"2024070511392275600_CIT0021","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J Clin Oncol"},{"issue":"14","key":"2024070511392275600_CIT0022","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2024070511392275600_CIT0023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/asheducation-2017.1.121","article-title":"Incidental venous thromboembolism: is anticoagulation indicated","volume":"2017","author":"Di Nisio","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2024070511392275600_CIT0024","first-page":"371","article-title":"Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer","volume":"106","author":"Menapace","year":"2011","journal-title":"Thromb Haemost"},{"issue":"5","key":"2024070511392275600_CIT0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/030089161209800509","article-title":"Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients","volume":"98","author":"Tiseo","year":"2012","journal-title":"Tumori"},{"issue":"2","key":"2024070511392275600_CIT0026","doi-asserted-by":"crossref","first-page":"1901697","DOI":"10.1183\/13993003.01697-2019","article-title":"Clinical implications of incidental venous thromboembolism in cancer patients","volume":"55","author":"Mulder","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"2024070511392275600_CIT0027","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"2024070511392275600_CIT0028","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"7","key":"2024070511392275600_CIT0029","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/ajh.26928","article-title":"External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center","volume":"98","author":"Li","year":"2023","journal-title":"Am J Hematol"},{"issue":"4","key":"2024070511392275600_CIT0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2017.09.015","article-title":"What impact does venous thromboembolism and bleeding have on cancer patients\u2019 quality of life","volume":"21","author":"Lloyd","year":"2018","journal-title":"Value Health"},{"issue":"2","key":"2024070511392275600_CIT0031","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/biom12020259","article-title":"Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment","volume":"12","author":"Canonico","year":"2022","journal-title":"Biomolecules"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/7\/575\/58449046\/oyae099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/7\/575\/58449046\/oyae099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:39:51Z","timestamp":1720179591000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/7\/575\/7679970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae099","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,22]]}}}